Log In
Print this Print this

GRC 27864

  Manage Alerts
Collapse Summary General Information
Company Glenmark Pharmaceuticals Ltd.
DescriptionMicrosomal prostaglandin E synthase-1 (PTGES; mPGES-1) inhibitor
Molecular Target Microsomal prostaglandin E synthase-1 (PTGES) (mPGES-1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat inflammatory disorders, such as osteoarthritis (OA) and rheumatoid arthritis (RA)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today